Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Challenges in medication clinical trials

M V Rudorfer1

  • 1Clinical Treatment Research Branch, National Institute of Mental Health, Rockville, MD 20857.

Psychopharmacology Bulletin
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Metabolites of Antidepressants in the Treatment of Depression.

CNS drugs·2016
Same author

ECT treatment does not enhance neuroendocrine responses to serotonergic challenge.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Progress in ECT research.

The American journal of psychiatry·1999
Same author

Metabolism of tricyclic antidepressants.

Cellular and molecular neurobiology·1999
Same author

Clinical research of the National Institute of Mental Health.

Psychopharmacology bulletin·1998
Same author

Women's mental health research--what is the need?

Psychopharmacology bulletin·1998
Same journal

Catatonia Associated with Psychosis: A Retrospective Study of 164 Inpatients.

Psychopharmacology bulletin·2026
Same journal

Escitalopram-Induced Spasmodic Torticollis in an Early Psychosis Service: A Case Report.

Psychopharmacology bulletin·2026
Same journal

Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship.

Psychopharmacology bulletin·2026
Same journal

Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD.

Psychopharmacology bulletin·2026
Same journal

When Care Becomes Dangerous: Patient Assaults Against Physicians.

Psychopharmacology bulletin·2026
Same journal

Efficacy and Safety of Centanafadine in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Psychopharmacology bulletin·2026
See all related articles

Medication clinical trials require careful methodology, including clear entry criteria and monitoring of drug levels. Child and adolescent psychopharmacology trials highlight the need for placebo controls and further research into dose-response relationships.

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Child and Adolescent Psychiatry

Background:

  • Medication clinical trials are fundamental to pharmacological therapy.
  • Ensuring study success requires meticulous attention to methodological issues beyond basic drug administration.
  • These principles are crucial, especially in emerging fields like child and adolescent psychopharmacology.

Purpose of the Study:

  • To outline essential methodologic considerations for successful medication clinical trials.
  • To discuss the application of these principles in child and adolescent psychopharmacology.
  • To highlight findings and limitations in current antidepressant trials for young populations.

Main Methods:

  • Defining clear diagnostic and severity criteria for participant eligibility.

Related Experiment Videos

  • Controlling for confounding biological and psychosocial factors.
  • Ensuring treatment adequacy through plasma drug concentration monitoring and understanding active metabolites.

    • Main Results:

    • Placebo control has been shown to be particularly important in trials involving young populations.
    • Controlled antidepressant trials in children and adolescents have demonstrated equivocal efficacy to date.
    • Limited understanding of dose (or plasma level)/response relationships hinders optimization of further studies.

    Conclusions:

    • Rigorous methodology, including robust outcome measures, is vital for effective medication clinical trials.
    • Further research is needed to optimize pharmacotherapy for child and adolescent psychiatric disorders.
    • Understanding dose-response relationships is key to advancing pediatric psychopharmacology.